Letter to the Editor
Fibroids through the ages: a historical journey and future prospects in myomectomy
Gynecology and Pelvic Medicine
2024;
7:
31
(30 September 2024)
Editorial Commentary
Is it time to add BRCA1 promoter methylation testing in the arsenal of ovarian cancer diagnostic tools?
Gynecology and Pelvic Medicine
2024;
7:
30
(30 September 2024)
Editorial Commentary
Beyond immunotherapy—treatment advances in cell-based therapy for ovarian cancer and associated challenges
Gynecology and Pelvic Medicine
2024;
7:
29
(30 September 2024)
Case Report
Uterine tumor with characteristics of ovarian sex-cord tumor: case report
Gynecology and Pelvic Medicine
2024;
7:
28
(30 September 2024)
Case Report
Clear-cell borderline tumor with pseudo-Meigs’ syndrome: a case report and review of the literature
Gynecology and Pelvic Medicine
2024;
7:
27
(30 September 2024)
Review Article
Uterine fibroids & infertility: which fibroids should be removed?—a narrative review
Gynecology and Pelvic Medicine
2024;
7:
26
(30 September 2024)
Review Article
Are there any limits for laparoscopic myomectomy?—tips & tricks
Gynecology and Pelvic Medicine
2024;
7:
25
(30 September 2024)
Review Article
Evolution of stress urinary incontinence (SUI) outcomes assessment: a narrative review
Gynecology and Pelvic Medicine
2024;
7:
24
(30 September 2024)
Review Article
Uterine fibroids: a narrative review of epidemiology and management, with a focus on uterine artery embolization
Gynecology and Pelvic Medicine
2024;
7:
23
(30 September 2024)
Original Article
Management and prognosis of uterine sarcoma in elderly
Gynecology and Pelvic Medicine
2024;
7:
22
(30 September 2024)
Original Article
Missed diagnosis of pelvic organ prolapse complicated with cervical cancer: a retrospective case series of five patients and review of literature
Gynecology and Pelvic Medicine
2024;
7:
21
(30 September 2024)
Editorial Commentary
Gynecologic reconstructive surgery: tailoring the postoperative care to the patient
Gynecology and Pelvic Medicine
2024;
7:
20
(30 June 2024)
Editorial Commentary
Polymorphism and pelvic organ prolapse: combining strict inclusion criteria and environmental risk factors as a good standard for further studies
Gynecology and Pelvic Medicine
2024;
7:
19
(30 June 2024)
Editorial Commentary
Commentary on “Age and postoperative opioid use in women undergoing pelvic organ prolapse surgery”
Gynecology and Pelvic Medicine
2024;
7:
18
(30 June 2024)
Editorial Commentary
Anterior pelvic organ prolapse repair: the intersection of science and art
Gynecology and Pelvic Medicine
2024;
7:
17
(30 June 2024)
Editorial Commentary
Pessary-related complications: a brief overview
Gynecology and Pelvic Medicine
2024;
7:
16
(30 June 2024)
Surgical Technique
Pulling the uterus directly instead of relying on the uterine manipulator: a better surgical technique choice for laparoscopic radical resection of cervical cancer
Gynecology and Pelvic Medicine
2024;
7:
15
(30 June 2024)
Case Report
Intrauterine vacuum-induced hemorrhage-control device for hemorrhage after myomectomy: a case report and review of the literature
Gynecology and Pelvic Medicine
2024;
7:
14
(30 June 2024)
Review Article
Scoping review of evidence-based postoperative recommendations following urogynecology surgery
Gynecology and Pelvic Medicine
2024;
7:
13
(30 June 2024)
Review Article
Evaluation and management of urinary incontinence in nursing home residents: unique considerations for an at-risk population
Gynecology and Pelvic Medicine
2024;
7:
12
(30 June 2024)
Original Article
A real-world research of cervical cancer screening in patients diagnosed with cervical cancer by loop electrosurgical excision procedure
Gynecology and Pelvic Medicine
2024;
7:
11
(30 June 2024)
Original Article
A survey in Liangshan, Sichuan showed higher human papillomavirus infection rate and cervical cancer risk for Yi Chinese compared to Han Chinese
Gynecology and Pelvic Medicine
2024;
7:
10
(30 June 2024)
Editorial Commentary
Exploring racial and ethnic disparities in cervical cancer’s histologic subtypes
Gynecology and Pelvic Medicine
2024;
7:
9
(30 March 2024)
Editorial Commentary
Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer
Gynecology and Pelvic Medicine
2024;
7:
8
(30 March 2024)
Editorial Commentary
Alterations in the MAPK pathway: promising biomarkers for MEK1/2 inhibition
Gynecology and Pelvic Medicine
2024;
7:
7
(30 March 2024)